Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Somnomed Ltd

SOM.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Medical Equipment, Supplies & Distribution ·

Australia Micro Cap Analyst: BUY

Last Close

$0.24

▼ -2.90%

Market Cap $53.13M · Vol 77.45K

Key Metrics

P/E Ratio

N/A

FWD: 12.33

Market Cap

$53.13M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

+356.95%

YoY

RSI (14)

35.71

Momentum

Beta

1.46

vs Market

52W High

$0.68

61.30% below

52W Low

$0.21

11.48% above

Volume

77.45K

Avg 48.00K

P/B

2.40

Price-to-book

ROE

N/A

Return on equity

Free Float

73.99%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Somnomed Ltd (SOM.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SOM.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.90%

-16.25%

-42.24%

-48.46%

YTD

-56.63%

-55.33%

-21.06%

-79.79%

Financials & Valuation

TTM · Annual

Total Revenue	$79.30M
Net Income	$-1,833,529.00
Revenue Growth (YoY)	-6.78%
Gross Margin	56.38%
Operating Margin	0.93%
Net Profit Margin	-2.31%
ROE	N/A
ROA · ROIC	-0.59% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	12.33
PEG Ratio	N/A
P/S	0.98
P/B	2.40
P/FCF	44.24
EPS Growth	+356.95%
Outstanding Shares	219.77M

Technical Indicators

50-Day SMA	$0.29
200-Day SMA	$0.42
RSI (14)	35.71
Beta	1.46
52-Week High	$0.68
52-Week Low	$0.21

Volume Today	77.45K
Avg Daily Volume (30D)	48.00K
Relative Volume	1.61x
Volatility (10D)	36.22
Volatility (30D)	60.13
Free Float	73.99%

Analyst Consensus

BUY

Current Price $0.24

Mean Target $0.54

52W Low$0.21 52W High$0.68

Current

Target

$0.21 $0.68

Current Analyst target

+127.25% upside potential · 3 analysts

Identifiers

ExchangeASX

FIGIBBG001SM6MG6

ISINAU000000SOM1

CountryAustralia

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateFeb 24, 2027

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

ABT Abbott Laboratories -1.78% MDT Medtronic PLC -0.29% COR Cencora, Inc. -0.73% 7741.T HOYA CORPORATION -0.32% BDX Becton Dickinson and Co -1.88%

Company Profile

SomnoMed Limited is engaged in producing and selling devices for the oral treatment of sleep-related disorders. It provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent Mandibular Advancement Splint and other oral devices for sleep-related disorders in Australia and overseas. Its segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.